87 related articles for article (PubMed ID: 9829533)
1. Ex vivo fibroblast transduction in rabbits results in long-term (>600 days) factor IX expression in a small percentage of animals.
Chen L; Nelson DM; Zheng Z; Morgan RA
Hum Gene Ther; 1998 Nov; 9(16):2341-51. PubMed ID: 9829533
[TBL] [Abstract][Full Text] [Related]
2. Long-term expression of human factor IX cDNA in rabbits.
Zhou JM; Qiu XF; Lu DR; Lu JY; Xue JL
Sci China B; 1993 Nov; 36(11):1333-41. PubMed ID: 8142022
[TBL] [Abstract][Full Text] [Related]
3. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
Chen L; Perlick H; Morgan RA
Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
[TBL] [Abstract][Full Text] [Related]
4. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
[TBL] [Abstract][Full Text] [Related]
5. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
Yao SN; Smith KJ; Kurachi K
Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
[TBL] [Abstract][Full Text] [Related]
6. Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents.
Brauker J; Frost GH; Dwarki V; Nijjar T; Chin R; Carr-Brendel V; Jasunas C; Hodgett D; Stone W; Cohen LK; Johnson RC
Hum Gene Ther; 1998 Apr; 9(6):879-88. PubMed ID: 9581910
[TBL] [Abstract][Full Text] [Related]
7. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
[TBL] [Abstract][Full Text] [Related]
8. Stage I clinical trial of gene therapy for hemophilia B.
Lu DR; Zhou JM; Zheng B; Qiu XF; Xue JL; Wang JM; Meng PL; Han FL; Ming BH; Wang XP
Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast transplantation in rats: transduction and function of foreign genes.
Neuzil D; Holzman M; Rozga J; Levine J; Moscioni AD; Demetriou AA
J Surg Res; 1993 Jun; 54(6):631-7. PubMed ID: 8412074
[TBL] [Abstract][Full Text] [Related]
10. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
Dai YF; Qiu XF; Xue JL; Liu ZD
Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
[TBL] [Abstract][Full Text] [Related]
11. Expression of biologically active human factor IX in human hematopoietic cells after retroviral vector-mediated gene transduction.
Hao QL; Malik P; Salazar R; Tang H; Gordon EM; Kohn DB
Hum Gene Ther; 1995 Jul; 6(7):873-80. PubMed ID: 7578406
[TBL] [Abstract][Full Text] [Related]
12. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
13. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice.
Kim HS; Kim JC; Lee YK; Kim JS; Park YS
J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610
[TBL] [Abstract][Full Text] [Related]
14. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells.
Hurwitz DR; Kirchgesser M; Merrill W; Galanopoulos T; McGrath CA; Emami S; Hansen M; Cherington V; Appel JM; Bizinkauskas CB; Brackmann HH; Levine PH; Greenberger JS
Hum Gene Ther; 1997 Jan; 8(2):137-56. PubMed ID: 9017418
[TBL] [Abstract][Full Text] [Related]
16. Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in rabbit model of hind limb ischemia.
Ishii S; Koyama H; Miyata T; Nishikage S; Hamada H; Miyatake S; Shigematsu H
J Vasc Surg; 2004 Mar; 39(3):629-38. PubMed ID: 14981459
[TBL] [Abstract][Full Text] [Related]
17. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
Lu D; Qiu X; Zheng B; Qiu X; Xue J
Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
[TBL] [Abstract][Full Text] [Related]
18. Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo.
White SJ; Page SM; Margaritis P; Brownlee GG
Hum Gene Ther; 1998 May; 9(8):1187-95. PubMed ID: 9625258
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
Krebsbach PH; Zhang K; Malik AK; Kurachi K
J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion.
Cherington V; Chiang GG; McGrath CA; Gaffney A; Galanopoulos T; Merrill W; Bizinkauskas CB; Hansen M; Sobolewski J; Levine PH; Greenberger JS; Hurwitz DR
Hum Gene Ther; 1998 Jul; 9(10):1397-407. PubMed ID: 9681411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
